How to buy Next Science shares
Own Next Science shares in just a few minutes.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Next Science Limited is a drug manufacturers-specialty & generic business based in Australia. Next Science shares (NXS) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Next Science has a trailing 12-month revenue of around $3.4 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Next Science
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Next Science . Find the share by name or ticker symbol: NXS. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Next Science reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Next Science . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Next Science share priceUse our graph to track the performance of NXS stocks over time.
Next Science shares at a glance
|52-week range||$1.1 - $2.06|
|50-day moving average||$1.7376|
|200-day moving average||$1.3909|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.08|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Next Science stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Next Science price performance over time
|1 week (2021-06-17)||24.59%|
|1 month (2021-05-24)||7.34%|
|3 months (2021-03-24)||39.19%|
|6 months (2020-12-24)||47.86%|
|1 year (2020-06-24)||33.80%|
|2 years (2019-06-24)||-50.65%|
Next Science financials
|Revenue TTM||$3.4 million|
|Gross profit TTM||$2.9 million|
|Return on assets TTM||-33.7%|
|Return on equity TTM||-62.24%|
|Market capitalisation||$301.9 million|
TTM: trailing 12 months
Next Science share dividends
We're not expecting Next Science to pay a dividend over the next 12 months.
Next Science share price volatility
Over the last 12 months, Next Science 's shares have ranged in value from as little as $1.1 up to $2.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Next Science 's is 0.4257. This would suggest that Next Science 's shares are less volatile than average (for this exchange).
Next Science overview
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies to eradicate issues in human health caused by biofilms. The company develops its products using its Xbio Technology platform. It offers SURGX, an antimicrobial gel designed to reduce surgical site and post-surgical infections; and BACTISURE, a surgical lavage that is used to wash out the surgery site and Intramedullary canal. The company also provides BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site and post-operative infections. It has strategic partnerships with Montana State University Center for Biofilm Engineering, Mayo Clinic, Texas Tech University Clinical Research Institute, Southwest Regional Wound Care Center, University of Florida Department of Otolaryngology, and Jacksonville Center for Clinical Research. Next Science Limited has operations in the United States and Australia. The company was founded in 2012 and is headquartered in Chatswood, Australia.
Frequently asked questions
More guides on Finder
Mobile plans are now more expensive, but here’s a hack to save $200 a year
Telstra, Optus, and Vodafone keep raising their prices even as the rest of the market is more affordable than ever.
Prime Day VR gaming deal: $60 off the Oculus Quest 2
Amazon is selling the standalone Oculus Quest 2 virtual-reality headset for $432.12. You can also score $77 off the 256GB version.
Barefoot Investor: How to watch Scott Pape’s Money Movement docu-series online
This fresh docu-series features the one and only Barefoot Investor.
Prime Day’s best health and fitness deals: Garmin, FitBit, PranaOn
Stocking up on your favourite supplements or adding to your home gym, Amazon has got you covered with these red-hot offers.
Amazon Prime Day’s best camera deals: Nikon, Panasonic and more
DSLR, digital, polaroids, lenses and accessories - these are the best camera deals Amazon has to offer this Prime Day.
Biggest Amazon Prime Day discounts: 75% off games + heaps more
Top offers so far include 75% off games, 68% off tech and 38% off alcohol.
Jetstar sale offers new route to “Australia’s most beautiful coastlines”
You have to be quick, these fares are gone with the strike of midnight.
Kobo Elipsa review: An ereader and enote 2-in-1
The Kobo Elipsa makes a valiant attempt to bridge the gap between eReader and eNote. It doesn’t manage to excel at being one or the other as its big for an eReader, and slow for an eNote.
Amazon Prime Day: Best board game offers on Hasbro, MONOPOLY, Jenga
From children to teens and adults, Amazon has got you covered with these awesome board game deals.
Ask an Expert